Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study

This study has been completed.
Sponsor:
Collaborators:
GlaxoSmithKline
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Bayer
ClinicalTrials.gov Identifier:
NCT01348880
First received: May 4, 2011
Last updated: May 16, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)